Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Immunity to Infection in Healthy Participants and Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
- Status
- UNKNOWN
- Phase
- N/A
Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over
- Status
- UNKNOWN
- Phase
- NA
The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention
- Status
- COMPLETED
- Phase
- N/A
Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites
- Status
- COMPLETED
- Phase
- N/A
eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services
- Status
- COMPLETED
- Phase
- N/A
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants
- Status
- UNKNOWN
- Phase
- PHASE1
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
- Status
- TERMINATED
- Phase
- PHASE2
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
- Status
- UNKNOWN
- Phase
- NA
A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People
- Status
- UNKNOWN
- Phase
- NA
A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China
- Status
- UNKNOWN
- Phase
- NA
A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China
- Status
- UNKNOWN
- Phase
- NA
Addressing Post-COVID-19 Musculoskeletal Symptoms
- Status
- COMPLETED
- Phase
- NA
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
- Status
- UNKNOWN
- Phase
- NA
Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE1